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Abstract
Background: MCF-10A cells are near diploid and normal human mammary epithelial cells. In
three-dimensional reconstituted basement membrane culture, they undergo a well-defined
program of proliferation, differentiation, and growth arrest, forming acinar structures that
recapitulate many aspects of mammary architecture in vivo. The pre-malignant MCF-10AT cells and
malignant MCF-10CA1a lines were sequentially derived from the MCF-10A parental cell line first
by expression of a constitutively active T24 H-Ras generating the MCF-10AT cell line. This was
followed by repeated selection for increasingly aggressive tumor formation from cells recovered
from xenograft tumors in immuno-compromised mice, generating the MCF-10CA1a cell line.
When inoculated subcutaneously into the flanks of immuno-compromised mice, MCF-10AT cells
occasionally form tumors, whereas MCF-10CA1a cells invariably form tumors with a shorter
latency than MCF-10AT derived tumors.
Results: MCF-10AT cells grown in three-dimensional basement membrane culture form complex
multi-acinar structures that produce a basement membrane but undergo delayed cell cycle arrest
and have incomplete luminal development. MCF-10CA1a cells grown in three-dimensional
basement membrane culture form large, hyper-proliferative masses, that retain few characteristics
of MCF10A acini and more closely resemble tumors.
Conclusion: Here we report on the growth and differentiation properties of these three matched
cell lines in three-dimensional basement membrane culture. Features of tissue morphogenesis were
assessed, including proliferation, basement membrane formation, polarization of alpha-6 beta-4
integrin to the basement membrane, formation of cell:cell junctions, and apoptosis for luminal
clearance. The matched series of normal MCF-10A, pre-malignant MCF-10AT, and malignant MCF-
10CA1a cells offers a unique opportunity to study the mechanisms of malignant progression both
in a three-dimensional microenvironment and in the same cell background.
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Background
Universal features of breast cancer include a loss of con-
trol of cell proliferation and organization, a loss of cell
polarity, as well as a loss of cell: cell adhesion and cell:
basement membrane adhesion. Monolayer cultures of
mammary epithelial cells do not closely mimic these fea-
tures of in vivo cell and tissue architecture [1,2], and also
do not recapitulate the alterations in nuclear structure
characteristic of breast tumors [3]. The development of
three-dimensional culture systems for mammary epithe-
lial cells has been an important advance in cell culture
models, more closely mimicking in vivo architecture and
are, therefore, more relevant systems in which to elucidate
changes in cell growth, cell: cell adhesion, cell: cell junc-
tions, and cell: extra-cellular matrix (ECM) interactions
that occur during malignant progression [1,4,5].
MCF-10 cells were derived from a patient with fibrocystic
disease and the immortalized MCF-10A line arose sponta-
neously in culture [6]. MCF-10 cells are diploid, while the
MCF-10A line has a stable, near-diploid karyotype [6,7]
with modest genetic modifications typical of culture-
adapted breast epithelial cells [8] including loss of the p16
locus [9]. The cells express normal p53 [9,10], they do not
form colonies in soft agar, and they do not grow in
immuno-compromised mice [11].
Several transformed lines have been derived from MCF-
10A cells. The MCF-10AT line was created by forced
expression of activated H-ras [12,13]. Implanted as
xenografts, MCF-10AT cells formed nodules that pro-
gressed from hyperplasia to carcinoma in situ in 25% of
mice [12,14]. Further selection for tumor formation in
mice generated the series of MCF-10CA1 cell lines that are
fully malignant, producing tumors in 100% of immuno-
compromised mice transplanted with the cells [15,16].
Thus, the MCF-10A series of matched cell lines provides a
complete spectrum of cell phenotypes, from normal to
pre-malignant to fully malignant.
MCF-10A cells cultured in three-dimensional reconstituted
basement membrane culture (rBM) develop important fea-
tures of normal breast tissue via a well described progression
of proliferation, cell cycle arrest, apical-basolateral polariza-
tion, and finally, apoptosis to create a luminal space
[9,17,18]. In addition, cell nuclei of MCF-10A cells forming
acini in three-dimensional rBM culture display a reorganized
and differentiated nuclear architecture more characteristic of
mammary epithelial cells in tissue than those cultured in
monolayer [3]. The resulting acini of MCF-10A three-dimen-
sional rBM cultures resemble those of normal breast tissue,
which are clustered in lobules that connect to intralobular
ductules that, in turn, connect to interlobular ducts.
The MCF10A series of cell lines provides a unique oppor-
tunity to probe malignant progression induced in a
molecularly defined way, in a common cell background.
We have characterized their ability to form tissue-like
structures in a three-dimensional microenvironment. In
contrast to MCF-10A cells, MCF-10ATcells, when cultured
in three-dimensional in rBM, form multi-acinar struc-
tures, and MCF-10CA1a cells, when also cultured in three-
dimensional in rBM, form large hyper-proliferative cell
aggregates with altered organization and no lumen. We
conclude that pre-malignant cells have lost normal prolif-
eration control but retain normal cell polarity, cell:cell,
and cell:basement membrane adhesion. Fully malignant
cells, on the other hand, have lost the ability to undergo
normal acinar morphogenesis. The application of three-
dimensional rBM culture to this unique progression series
of cell lines with a matched cell background provides a
physiologically relevant in vitro model of breast cancer
progression.
Results
Monolayer cultures
In monolayer culture, MCF-10A and MCF-10AT cells grew
in expanding colonies with the cobblestone appearance
characteristic of epithelial cells. (Figure 1A, B) MCF-
10CA1a cells had a less cobblestone-like appearance,
occasionally had a more spindle-like shape and fibroblas-
tic appearance, and often had cytoplasmic vacuoles (Fig-
ure 1C). This is consistent with previous reports of
morphological changes and a more mesenchymal appear-
ance for MCF-10CA1a cells [15].
Multi-acinar and hyper-proliferative mass formation in 
three-dimensional culture by MCF-10AT and MCF-
10CA1a cells respectively
Parental MCF-10A, pre-malignant MCF-10AT, and malig-
nant MCF-10CA1a cell lines were cultured in rBM. In this
procedure, cells were plated on a layer of rBM with an
overlay created by adding rBM to the culture medium [9].
After two days, cultures of all three cell lines formed simi-
larly-sized spherical masses of cells (Figure 2A, G, M).
After 4 days, the masses of MCF-10AT and MCF-10CA1a
cells were larger than the masses of MCF-10A cells (Figure
2B, H, N), an indicator of increased proliferation. After 8
Cell colony morphology observed for MCF-10A, MCF-10AT, and MCF-10CA1a cells grown in m nolayerFigure 1
Cell colony morphology observed for MCF-10A, 
MCF-10AT, and MCF-10CA1a cells grown in monol-
ayer. Phase contrast images of normal MCF-10A (A), trans-
formed MCF-10AT (B) and malignant MCF-10CA1a (C) 
grown in monolayer. Scale bar, 100 μm.
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days in three-dimensional culture, the MCF-10AT struc-
tures had an acinar appearance but these acini were larger
than those for the parental MCF-10A cells and were more
irregular in shape (Figure 2C and 2I).
Between days 8 and 12 in three-dimensional culture, the
MCF-10A acini continued to increase in size while retain-
ing their overall spherical shape (Figure 2C, D). During
this same time, MCF-10AT acini not only continued to
increase in size, but also in many cases appeared to have
generated a multi-acinar structure (Figure 2I, J). Although
some of the MCF-10CA1a structures at day 12 remained
the same size as on day 8 they often appeared darker and
denser. Other MCF-10CA1a structures appeared to be
masses of disorganized cells that continued to increase in
size between days 8 to day 12 (Figure 2O, P).
From day 12 to day 20 in three-dimensional culture, the
MCF-10A acini did not appreciably change in size or
shape, consistent with a cessation of proliferation [4,9].
Acini remained spherical with a smooth outer edge and
when the peripheral edge of the acinus was in the focal
plane, individual cells at that edge appeared of uniform
size and were evenly spaced (arrow panel F). A few acini
were no longer spatially separated, but were touching by
these later time points (Figure 2E, F). They did not, how-
ever, appear to be fused into a single structure. The multi-
acinar MCF-10AT structures continued to increase in size
from day 16 to day 20 (Figure 2K, L). By days 16 to 20,
MCF-10CA1a structures were larger and even more easily
distinguishable from those of the MCF-10A and MCF-
10AT (Figure 2Q, R). Since the growth of MCF10CA1a
cells in three-dimensional culture was variable, a spec-
trum of typical morphologies observed at 20 days in
three-dimensional culture is presented in Figure 3. Some
masses of MCF-10CA1a cells were large and very dense
with uneven edges (Figure 3A); whereas other masses
lacked distinct edges, were less dense, and were more
spread (Figure 3B). Some structures were very large with
round, smooth outer edges and a vacuolar interior (Figure
3C). We also continued to see both masses of cells that did
not appear organized as well as remnants of cells that
failed to thrive in three-dimensional culture (Figure 3D).
Quantification of the sizes of structures formed by the
three cell lines in three-dimensional culture is presented
in Figure 4. The size of MCF-10A acini stabilized after 12
days in three-dimensional culture, consistent with an end
to proliferation at this time. At 20 days in three-dimen-
sional culture MCF-10A acini had a mean diameter of
66.4 ± 17.7 μm. In contrast, the size of MCF-10AT multi-
acinar structures stabilized after 16 days in three-dimen-
sional culture, suggesting a delay of the end of prolifera-
tion in this cell line in three-dimensional culture. At 20
days in three-dimensional culture the MCF-10AT multi-
acinar structures had a mean diameter of 109.7 ± 39.2 μm.
The MCF-10CA1a masses continued to increase in size for
the entire 20 day period, indicating a loss of proliferation
control in this cell line. MCF-10CA1a masses averaged
205.4 ± 97.5 μm at 20 days in three-dimensional culture.
The size of the structures resulting from growth in rBM,
were not significantly different among the three cells lines
from day 2 to day 8 in three-dimensional culture. How-
ever, by day 12 and continuing until day 20, the MCF-10A
acini were significantly smaller than the MCF-10CA1a
masses as determined by an ANOVA test followed by a
Tukey adjustment (Figure 4). At day 16 the MCF-10A acini
were also significantly smaller than the MCF-10AT multi-
acinar structures (Figure 4).
In summary, MCF-10AT cells grown on rBM formed
multi-acinar structures. MCF-10CA1a cells grown in rBM
developed into hyper-proliferative cellular masses that
did not resemble acini. Thus, the malignant MCF-10CA1a
cells grown in three-dimensional culture showed
increased proliferation and decreased organization com-
pared to both normal MCF-10A and pre-malignant MCF-
10AT cells.
Lack of programmed cell death in MCF-10AT and MCF-
10CA1a cells in three-dimensional cultures
After 6 days in three-dimensional culture MCF-10A acini
were negative for activated caspase-3, a marker of apopto-
sis, but they were positive at days 12 and 20 although
there were consistently fewer activated caspase positive
cells at day 20 (Table 1, Figure 5A, J, S). Caspase-3 staining
was observed in the center of the structures but also in sin-
gle cells at the outer edge of acini. The MCF-10AT cells, on
Morphology observed for MCF-10A, MCF-10AT, and MCF-10CA1a cells grown in rBM for 2  daysFigure 2
Morphology observed for MCF-10A, MCF-10AT, and 
MCF-10CA1a cells grown in rBM for 20 days. Phase 
contrast images of normal MCF-10A cells were cultured in 
overlay rBM for 2, 4, 8, 12, 16, and 20 days (top, A to F). 
Transformed MCF-10AT cells (middle, G to L) and malignant 
MCF-10CA1a cells (bottom, M to R) were cultured in three-
dimensions at the same time points. Scale bar, 100 μm. Nor-
mal MCF-10A cells increase in size to day 8 and form polar-
ized spherical acini. Transformed MCF-10AT cells increase in 
size for 20 days, retain polarity, and form multi-acinar struc-
tures. Malignant MCF-10CA1a cells continue to proliferate 
throughout the 20 days and form large, complex masses.
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the other hand, were negative for activated caspase-3
throughout the entire 20-day experiment (Table 1, Figure
5D, M, V). Thus, although MCF-10AT cells formed multi-
ple acinar structures, the lack of activated caspase-3 stain-
ing suggests that the programmed cell death that occurs
during MCF-10A lumen formation [17] did not occur. In
contrast to MCF-10AT, activated caspase-3 staining was
observed in proliferating, malignant MCF-10CA1a struc-
tures at days 6, 12 and 20 in rBM culture (Table 1, Figure
5G, P, Y). Apoptotic cells were observed both within and
at the outer edges of MCF-10CA1a masses.
Lack of proliferation control in MCF-10AT and MCF-
10CA1a cells in three-dimensional cultures
Staining with Ki-67, a marker of cell proliferation [19],
indicated that malignant MCF-10CA1a masses continued
to proliferate even after 20 days in rBM culture (Figure 6I).
By this time, both the MCF-10A and the pre-malignant
MCF-10AT cultures had undergone growth arrest and did
not have detectable Ki-67 staining (Figure 6A, E). β4
integrin was expressed in structures for all three cell types
and was polarized to the outer surfaces of those structures
(Figure 6B,F,J). In MCF-10A acini and in MCF-10AT
multi-acini, basement membrane formation was com-
plete and limited to the outer edges of the structures (Fig-
ure 7B, F). Note the MCF-10A acinus shown in Figure 6B
had a notch or invagination with β4 integrin staining,
indicative of an irregular surface profile rather than com-
promised polarity. The basement membrane did not com-
pletely surround MCF-10CA1a masses and was also
Range of morphologies observed for MCF-10CA1a cells grown in rBM for 20 daysFigure 3
Range of morphologies observed for MCF-10CA1a 
cells grown in rBM for 20 days. Phase contrast micro-
graphs of malignant MCF-10CA1a cells after 20 days in over-
lay three-dimensional culture which form large defined dense 
masses (A), more spread, less defined masses (B), highly vac-
uolar acini (C), and clusters of MCF-10CA1a cells that have 
failed to thrive in rBM (D). Scale bar, 100 μm.
Size distributions observed for MCF-10A, MCF-10AT, and MCF-10CA1a cells grown in rB  for 20 daysFigure 4
Size distributions observed for MCF-10A, MCF-
10AT, and MCF-10CA1a cells grown in rBM for 20 
days. The significance of size difference between MCF-10A 
(green), MCF-10AT (yellow), and MCF-10CA1a (red) cells 
grown in overlay rBM culture was determined by analysis of 
variance followed by a Tukey t-test. Data are presented as 
means ± SEM (n = 10). Asterisks depict statistically significant 
differences between groups shown (*p < 0.05, ** p < 0.001).
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detected at multiple edges within a single mass (Figure
6J).
Heterogeneous cell: cell junction formation in MCF10-
CA1a cells in three-dimensional cultures
Staining of MCF-10A acini for cadherin after 20 days in
three-dimensional culture showed clearly defined cell:cell
boundaries (Figure 7A). On the same day, MCF-10AT
multi-acinar structures also had cadherin at cell:cell
boundaries with a more heterogeneous level of expression
from cell to cell (Figure 7E). MCF-10CA1a masses had
some cadherin at cell:cell boundaries but, unlike struc-
tures for the other two cell lines, had high concentrations
of cadherin at multiple basal surfaces (Figure 7I). Laminin
V expression in MCF-10A cells showed a clearly defined
basement membrane surrounding the acinus (Figure 7B),
confirming localization of laminin V as reported previ-
ously [9]. Similarly, laminin V expression showed a well
defined basement membrane surrounding the MCF-10AT
multi-acinar structure (Figure 7F), however laminin V
expression revealed an incomplete basement membrane
Apoptosis observed for MCF-10A, MCF-10AT and MCF-10CA1a cells grown in three-dimensional cultureFigure 5
Apoptosis observed for MCF-10A, MCF-10AT and 
MCF-10CA1a cells grown in three-dimensional cul-
ture. Single confocal sections of activated caspase-3 staining 
(left) and nuclear staining with Draq 5 (middle) with matching 
differential interference contrast images (DIC-right) of MCF-
10A acini in overlay three-dimensional culture at day 6 (A-C), 
day 12 (J-L) and day 20 (S-U); MCF-10AT multi-acinar struc-
tures at day 6 (D-F), day 12 (M-O), and day 20 (V-X); and 
MCF-10CA1a structures at day 6 (G-I), day 12 (P-R), and day 
20 (Y-AA). Scale bars, 50 μm. Activated caspase 3 positive 
cells were observed at day 12 and 20 for MCF-10A acini, 
were not observed for MCF-10AT multi-acinar structures 
and were observed at days 6, 12, and 20 for MCF-10CA1a 
masses. The speckled fluorescence outside the acini is from 
the Matrigel (panel S).
Table 1: Caspase-3 activation observed for MCF-10A, MCF-
10AT, and MCF-10CA1a cells grown in three-dimensional 
culture.
Day 6 Day 12 Day 20
MCF-10A - + +
MCF-10AT - - -
MCF-1-CA1a + + +
Caspase-3 activation was positive for MCF-10A cells grown in three-
dimensional culture at days 12 and 20. MCF-10AT cells were negative 
for caspase-3 activation throughout the experiment, while MCF-
10CA1a cells were positive for caspase-3 activation throughout the 
experiment.
Ki-67 and β4 integrin staining observed for MCF-10A, MCF-10AT, and MCF-10CA1  cells in th e -dimensional cultureF gure 6
Ki-67 and β4 integrin staining observed for MCF-10A, 
MCF-10AT, and MCF-10CA1a cells in three-dimen-
sional culture. MCF-10A (top), MCF-10AT (middle), and 
MCF-10CA1a (bottom) cell lines stained to examine prolifer-
ation and basement membrane formation during growth in 
overlay three-dimensional culture. Single confocal sections 
stained for Ki-67 (A, E, I) indicate that only MCF-10CA1a 
cells continue to proliferate at day 20 in three-dimensional 
culture. β4 integrin (B, F, J) staining detects basement mem-
brane deposition for all three cell lines. Nuclei were stained 
with Draq5 (C, G, K) and matching differential interference 
contrast images are shown (D, H, L). Scale bars, 50 μm.
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with long interior stretches in MCF-10CA1a masses (Fig-
ure 7J). This latter observation, along with the decrease in
β4 integrin polarity (Figure 6J), suggested that the loss of
cell and tissue polarity is a general feature for this fully
malignant MCF-10CA1a cell line.
Altered morphology of MCF-10CA1a cells cultured under 
different three-dimensional culture conditions
When MCF-10AT and MCF-10CA1a cells were cultured
under a lower Matrigel rBM overlay concentration of 0.5%
(compared to the usual 2%), highly branched structures
with connections between masses, were formed instead of
multi-acinar structures or undifferentiated masses (Figure
8C, D, E, F). In contrast, normal MCF-10A cells formed
spherical acini under a 0.5% Matrigel overlay (Figure 8A,
B) that were similar to those formed with the higher con-
centration 2% Matrigel overlay (Figure 2). After as early as
2 days in three-dimensional culture under 0.5% Matrigel,
both MCF-10AT and MCF-10CA1a cells formed long,
thin, branched structures (data not shown). In pre-malig-
nant MCF-10AT three-dimensional cultures these struc-
tures thickened and retained distinct edges between days
6 and 20 (Figure 8C, D). Malignant MCF-10CA1a cul-
tures, however, showed a proliferation of cells from the
edges of the structures from day 2 to day 6 (data not
shown), which continued through day 20. (Figure 8E, F).
Malignant MCF-10CA1a cells can be maintained in mon-
olayer culture in minimal media that lacks hydrocorti-
sone, EGF, insulin, and cholera toxin, whereas the MCF-
10A and MCF-10AT cells cannot [15]. When MCF-
10CA1a cells were maintained in three-dimensional cul-
ture under these minimal media conditions, the resulting
cultures displayed large, heterogeneous structures, how-
ever, these masses were somewhat more spread and less
dense than when the cultures were maintained in com-
plete media (Figure 8G, H).
Reversion of MCF10AT cells to single acini formation in 
embedded three-dimensional cultures
To this point, all observations were made from overlay
cultures where cells were plated on a Matrigel layer and
overlaid with media containing Matrigel. We subse-
quently compared characteristics of each cell line when
three-dimensional cultures were established by embed-
ding the cells in the lower layer of Matrigel and without
Cadherin and Laminin V staining observed for MCF-10A, MCF-10AT, and MCF-10CA1a cells in three-dimensional cul-tureFigure 7
Cadherin and Laminin V staining observed for MCF-
10A, MCF-10AT, and MCF-10CA1a cells in three-
dimensional culture. MCF-10A (top), MCF-10AT (mid-
dle), and MCF-10CA1a (bottom) cell lines stained to examine 
cell:cell junctions and basement membrane formation during 
growth in overlay three-dimensional culture for 20 days. Sin-
gle confocal sections of cadherin (A, E, I) demonstrate the 
existence of cell: cell junctions for all three cell lines at day 20 
in three-dimensional culture. Laminin V (B, F, J) staining indi-
cates basement membrane deposition for all three cell lines. 
Nuclei were stained with Draq5 (C, G, K) and matching dif-
ferential interference contrast images are shown (D, H, L). 
Scale bars, 50 μm. Morphology observed for MCF-10A, MCF-10AT, and MCF-10CA1a cells grown in three-dimensional culture u er vary-ing conditionsFi ure 8Morphology observed for MCF-10A, MCF-10AT, and 
MCF-10CA1a cells grown in three-dimensional cul-
ture under varying conditions. Phase contrast images of 
MCF-10A (A, B), MCF-10AT (C, D) and MCF-10CA1a (E, F) 
grown in overlay conditions at a low (0.5%) concentration of 
Matrigel. MCF-10A cells form spherical acini; MCF-10AT 
transformed cells form long, branched structures that 
thicken between days 6 and 20. MCF-10CA1a cells form 
interconnected masses of cells. Phase contrast images of 
MCF-10CA1a cells grown in overlay rBM in complete (G) 
and minimal (H) media. MCF-10CA1a cells at day 18 in 3D 
culture appear less dense and more spread under the mini-
mal media conditions. Scale bars, 100 μm.
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including Matrigel in the overlay medium. MCF-10A acini
were slightly smaller and more homogeneous in size than
when grown in overlay culture, as was previously
reported, [17], but otherwise showed no significant differ-
ence in apoptosis, basement membrane deposition, or the
formation of cell:cell junctions (data not shown). Simi-
larly, the malignant MCF-10CA1a cells showed little dif-
ference when the two culture methods were compared
(data not shown). However, in embedded culture, MCF-
10AT cells formed single acini with irregular edges (Figure
9), but did not form the multi-acinar structures seen in
overlay three-dimensional cultures (Figure 2). As previ-
ously noted (Figure 5), there was no staining for the apop-
tosis marker, activated Caspase 3 (Figure 9C), while
laminin V containing basement membrane deposition
occurred at the basal surface (Figure 9H) with β4 integrin
polarized to that surface (Figure 9D). Cadherin labeling
indicated that cell:cell junctions formed in the embedded
MCF-10AT cultures (Figure 9G), though we noted that
cells at the basal surface of these structures consistently
lacked cadherin staining.
Discussion
The MCF-10A progression series grown in three dimen-
sional rBM cultures can be a powerful system for studying
human mammary tumorigenesis. All three cell lines
derive from a common ancestor and the manipulations
that have made them increasingly transformed are well
defined. While much can be learned by studying these
cells in traditional two dimensional tissue culture, real
malignant transformation takes place within a three
dimensional tissue. The three dimensional rBM system we
have utilized to characterize these cells recapitulates much
more of the microenvironment of a tissue and allows for
a more detailed investigation of the dynamic and recipro-
cal crosstalk between the extracellular matrix and nuclear
gene expression that may play an important role in real
breast tumorigenesis [1,3,5,17,18]. In this study, we
assessed cellular parameters of tissue formation in cells of
the MCF-10A progression series and documented them as
a faithful model of mammary malignant progression.
Variants of differing malignancy have been developed
from the first normal human mammary epithelial cell
line, HMT-3522 [20], by spontaneous transformation
with selection for EGF-independent growth [21-23]).
These variants, cultured in rBM, have offered significant
insights into tumor progression [24-27]. However, the
molecular mechanisms driving these cells toward malig-
nancy were not defined in advance, although some infor-
mation about the process might be inferred from gene
expression studies of the established lines [28].
MCF-10A cells were manipulated by the forced expression
of a mutated H-ras-1, which is the human analog of the
Harvey sarcoma virus oncogene. This constitutively active
Ras variant, which was originally isolated from the blad-
der carcinoma cell line T24, has a single base mutation
causing an amino acid change at residue 12 (Gly to Val)
[29]. When injected into nude mice, the resulting MCF-
10AT cells persisted as xenografts and ultimately devel-
oped into carcinomas 25% of the time [12,13]. In tissue
culture studies, expression of this constitutively activated
Ras induced transformation of immortalized NIH3T3
cells and of primary rat and hamster cells from multiple
tissues, whereas the normal Ras did not [29,30]. While
few established breast cancer cell lines have Ras muta-
tions, a majority have Ras overexpression via amplifica-
tion of the gene [31-33]. More recently, activating
mutations in H-ras, K-ras, or N-ras were observed in 8 out
of 40 human breast cancer cell lines, with another 4 lines
having activating mutations in B-Raf, which is down-
stream in the Ras pathway [34]. Although only 5% of
breast tumors have activating Ras mutations [31], it was
shown that more than half had a 2- to 6-fold increase in
Ras expression and a more than 5-fold activation in down-
stream MAP Kinase activity [35]. Thus, Ras signaling may
be more commonly activated in breast tumor cells by
mechanisms other than mutation. In MCF-10A cells,
ErbB1-ErbB2 heterodimerization disrupts acinar tissue
structure in three dimensional basement membrane cul-
tures and generates a more invasive phenotype [36]. The
invasive phenotype was reverted by inhibition of the Ras/
MAP Kinase pathway, supporting a role for the Ras path-
way in the malignant progression of ErbB2 expressing
tumors. For these reasons, the ectopic expression of acti-
vated Ras in MCF-10A cells is likely relevant to the mech-
anisms of patient breast tumor progression.
Altered morphology of MCF-10AT cells in grown for 20 days in embedded three-dimensional cultureFigure 9
Altered morphology of MCF-10AT cells in grown for 
20 days in embedded three-dimensional culture. Dif-
ferential interference contrast (DIC) images (A, E) show that 
MCF-10AT cells grown under these conditions form irregu-
lar acini but not the multi-acinar structures seen in overlay 
cultures (see Figure 2). Nuclei were stained with Draq5 (B, 
F). Apoptosis, cell:cell junctions, and basement membrane 
formation were assessed by confocal microscopy with cas-
pase-3 (C), cadherin (G), β4 integrin (D), and Laminin V (H) 
staining. Scale bars, 10 μm.
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While MCF-10AT cells and normal MCF-10A cells grown
in three-dimensional reconstituted basement membrane
culture both exhibited growth arrest, this arrest appeared
to be delayed in the MCF-10AT cells. These cells also dem-
onstrated a nearly complete lack of apoptosis, resulting in
the absence of notable lumen formation. A recently pub-
lished report indicated that in MCF-10AT cells grown in
three-dimensional culture, apoptosis was decreased, but
not absent, leading to reduced lumen formation [37].
MCF-10AT cells were normal or nearly normal in their
ability to deposit basement membrane and to form
cell:cell junctions. Thus the activation of Ras predomi-
nantly affects the proliferation state of the cells in three-
dimensional culture, consistent with the idea that these
cells recapitulate aspects of breast tissue hyperplasia in
vivo [38].
In contrast, the malignant MCF-10CA1a cells never exhib-
ited growth arrest and never formed normal acinar struc-
tures, consistent with reports comparing primary
mammary epithelial cells, primary breast tumor cells, and
transformed breast cancer cell lines [4]. The MCF-10CA1a
cells exhibited unchecked proliferation in three-dimen-
sional culture despite the continuous occurrence of apopto-
sis, suggesting the loss of normal growth controls. In
addition, the MCF-10CA1a cells showed an incomplete
deposition of basement membrane proteins and abnormal
cell:cell contacts. Interestingly, the expression levels of the
markers assayed in these experiments were not significantly
altered. Instead, the proper structural organization of the
proteins within the cells was compromised. These pheno-
types are consistent with more advanced stages of tumori-
genesis, at which the dynamic relationships between
cell:cell interaction and cell:ECM contact are altered [1,39].
These progressively malignant cell lines were engineered
in the same cell background by a defined series of manip-
ulations. They recapitulate tumor phenotypes in a three
dimensional culture system, and this will facilitate future
studies of malignant progression. Compared to in vivo
studies, organotypic culture systems are easier and less
expensive to manipulate, facilitate fluorescence based
microscopy imaging, have a reduced complexity of cell
types in a simplified microenvironment, and are influ-
enced by a reduced number of uncontrolled factors. This
simplicity can be a disadvantage, ignoring features not
included in the tissue culture, but it can also be a great
advantage for mechanistic studies of malignant changes.
Of particular interest is the potential use of these cell lines
in three dimensional culture to dissect the signal transduc-
tion pathways, and especially the ras pathway, that drive
these cells to increasing malignancy.
Conclusion
Cancer arises from a complex interaction of factors includ-
ing both genetic changes as well as changes in the micro-
environment [40,41]. We have combined the isogenic
MCF-10A progression series of cell lines, where cells have
been pushed toward malignancy by a defined molecular
manipulation, with a three dimensional tissue culture sys-
tem that has already provided powerful insights into
breast tissue morphogenesis and tumorigenesis. The
results show that this progression series can be an excel-
lent model system for the better understanding of breast
cancer.
Methods
Cell Culture
MCF-10A, MCF-10AT (formally known as MCF-
10AneoT), and MCF-10CA1a cells were obtained from the
Barbara Ann Karmanos Cancer Institute (Detroit, MI). The
three cell lines were maintained in monolayer in Dul-
becco's modified Eagle's medium-F12 (DMEM/F12) (Inv-
itrogen, 21041025) supplemented with 5% horse serum
(Invitrogen, 16050122), 1% penicillin/streptomycin
(Invitrogen, 15140122), 0.5 μg/ml hydrocortisone
(Sigma, H-0888), 100 ng/ml cholera toxin (Sigma, C-
8052), 10 μg/ml insulin (Sigma, I-1882), and 20 ng/ml
recombinant human EGF (Peprotech, 100-15).
Three-dimensional Cell Culture
MCF-10A, MCF-10AT, and MCF-10CA1a cells were cul-
tured on plastic tissue culture dishes (Nalge Nunc,
Rochester, NY,172958) in either Reduced Growth Factor
Matrigel without phenol red or Non-Reduced Growth Fac-
tor Matrigel with phenol red (BD Biosciences, San Jose,
CA, #3562312 and #356234) following either the overlay
or embedded procedures of Debnath et. al. [9]. Briefly, for
overlay cultures, cells were prepared for three-dimen-
sional culture by growing to 20–80% confluency in mon-
olayer and seeding in a single cell suspension on 100 μl of
Matrigel in a 35mm plate at 7,000 to 15,000 cells/plate or
on 40 μl Matrigel in a 4 well chamber slide (Nunc, Lab-
Tek, 177399) at 5000 cells/well. For embedded cultures,
cells were grown up to 80% confluence in monolayer cul-
ture and plated at 2.5 × 104 cells/ml in 300 μl Matrigel, on
top of a thin layer of 75 μl Matrigel, in each well of a 4 well
chamber slide (see Figure 8A). In addition, some overlay
three-dimensional cultures of MCF-10CA1a cells were
prepared with cells grown in monolayer under minimal
media conditions, consisting of DMEM/F12 with 5%
horse serum, 0.029M sodium bicarbonate, 10mM HEPES
and 1% penicillin/streptomycin (see Figure 8, panels G
and H).
Once plated on rBM, all cultures were incubated at 37°C
in a 5% CO2 humidified incubator for up to 20 days.
Three-dimensional cultures were grown in assay media [9]
consisting of DMEM/F12 containing 2% horse serum, 5
ng/ml EGF, and 2% Matrigel (for overlay cultures only).
Media was replaced every 2 or 4 days. Morphology was
observed every 2 days via phase contrast microscopy. Size
Cancer Cell International 2009, 9:7 http://www.cancerci.com/content/9/1/7
Page 9 of 11
(page number not for citation purposes)
of resulting structures were measured every 2 days and
analyzed via an analysis of variance (ANOVA) test fol-
lowed by a Tukey adjustment.
Cryoblock Preparation
MCF-10A, MCF-10AT, and MCF-10CA1a cells were har-
vested at day 6, 12 or 20 by first washing with warm assay
media, followed by fixing with 4% formaldehyde in PBS
for 20 minutes at room temperature, then permeabilizing
with 0.5% Triton X-100 in PBS for 10 minutes at 4°C.
Cultures were rinsed with a glycine rinse (130 mM NaCl,
7 mM Na2HPO4, 3.5 mM NaH2PO4, 100 mM glycine)
three times for 20 minutes each at room temperature, fol-
lowed by a blocking step with TBS-1 (10 mM Tris HCL,
pH 7.7, 150 mM NaCl, 3 mM KCl, 1.5 mM MgCl2, 0.05%
(v/v) Tween 20, 0.1% (w/v) bovine serum albumin, 0.2%
(w/v) glycine) for 30 to 40 minutes at room temperature.
Cultures were transferred to 1.5 ml Eppendorf tubes; TBS-
1 was aspirated and replaced with 15% sucrose for 15
minutes at room temperature, aspirated, and replaced
with 30% sucrose for 15 minutes at room temperature.
Sucrose was replaced with Tissue Tek O.T.C. compound
(Sakura Finetek, #4583, Torrance, CA) or with TBS Tissue
freezing medium (Triangle Biomedical Sciences, H-TFM,
Durham, NC) and samples were flash frozen in liquid
nitrogen and stored at -80°C.
Immunofluorescence
Antibodies used for immunostaining included β4 integrin
(Chemicon, MAB#1964), human Laminin V (Chemicon,
MAB#19562), pan-Cadherin(Sigma, #C3678), Ki-67
(Zymed, #18-0191), and cleaved Caspase 3 (Cell Signal-
ing, #9664).
To immunostain three-dimensional samples, a thin layer
of Matrigel (10 μl) was used to coat the bottom of each
well of a 4-well slide and allowed to gel for at least 20
minutes at 37°C. A 10 or 20 μl sample of cells was layered
on top of the thin Matrigel layer and incubated for at least
20 minutes at 37°C. Samples were then washed with
warm media, followed by one of three fixing methods.
Cells were either fixed and then permeabilized or perme-
abilized and then fixed using 4% formaldehyde in PBS for
20 minutes at room temperature as the fixative, and using
0.5% Triton X-100 in PBS, 10 minutes at 4°C for permea-
bilization. Alternatively, for caspase staining (Figure 5)
cultures were fixed with methanol: acetone (1:1) for 20
minutes at -20°C. Following all fixation methods, sam-
ples were rinsed with a glycine rinse, 3 times for at least 10
minutes each time while rocking gently. This step was fol-
lowed by a block with IF buffer (130 mM NaCl, 7 mM
Na2HPO4, 3.5 mM NaH2PO4, 7.7 mM NaN3, 0.1%
Bovine Serum Albumin, 0.2% Triton X-100, 0.05% Tween
20) containing 10% goat serum (Invitrogen, #10000C)
for 1 hour 30 minutes, followed by a secondary block in
IF buffer containing 10% goat serum and 20 μg/ml F(ab')2
(Jackson Laboratories, #115-006-006) for 30 to 40 min-
utes. Samples were incubated with primary antibodies in
secondary block solution overnight at 4°C. Antibody con-
centrations used were β4 integrin (1:20), Laminin V and
pan-cadherin (1:200), Ki-67 and estrogen receptor
(1:100), and caspase (1:200). Samples were washed three
times for 20 minutes in IF buffer while gently rocking, fol-
lowed by a 1-hour incubation with the appropriate Alexa-
conjugated secondary antibodies (Molecular Probes) at a
concentration of 1:200. Nuclei were counterstained with
Draq 5 (Alexis Biochemicals, BOS-889-001-R200) prior to
a final wash with PBS and mounting with Prolong Anti-
fade Kit (Molecular Probes, P-7481, Eugene OR).
To immunostain cryo-sections, they were first allowed to
warm to room temperature in a humidity chamber for 15
minutes. All subsequent steps, except primary antibody
incubation, were carried out at room temperature. The
sections were washed with PBS with 0.05% Tween 20 for
20 minutes. Sections were blocked with IF buffer contain-
ing 10% goat serum for 1 hour 30 minutes, followed by a
second block in IF buffer, 10% goat serum and 20 μg/ml
F(ab')2 for 30 to 40 minutes. Sections were washed for 20
minutes in Signal Enhancer (Image-iT FX, Invitrogen,
#136933) and incubated with primary antibodies in IF
buffer with 10% goat serum overnight at 4°C. Antibody
concentrations were as described above. Sections were
washed three times for 20 minutes each in IF buffer fol-
lowed by 1 hour incubation with appropriate secondary
antibodies (Molecular Probes) at a concentration of
1:2000. Sections were again rinsed 3 times with IF buffer
for 20 minutes each followed by labeling with Draq 5, and
a final wash with PBS before mounting with Prolong Anti-
fade Kit. Images were captured using laser scanning confo-
cal microscopy with a Leica SP1.
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